Ypsomed Holding AG (XSWX:YPSN) Price-to-Funds-From-Operations: (As of Sep. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:YPSN Ypsomed Holding AG XSWX:YPSN
92 GF Score
Price CHF354.00
GF Value CHF394.11
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ypsomed Holding AG Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.

XSWX:YPSN
92GF Score
Ypsomed Holding AG XSWX:YPSN
Price-to-Funds-From-Operations is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF354.00 is trading 10.2% below its estimated GF Value™ of CHF394.11. GuruFocus considers Ypsomed Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:YPSN:

  • Price-to-Funds-From-Operations:
  • GF Value™: CHF394.11 vs. price of CHF354.00 (10.2% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ypsomed Holding AG Business Description

Other Exchanges YPSNz:UK0QLQ:UKOWX:Germany
Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
92GF Score

Get the complete analysis for XSWX:YPSN

Price-to-Funds-From-Operations is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF354.00
Price
CHF394.11
GF Value